Literature DB >> 22753769

Mortality with congenital heart defects in England and Wales, 1959-2009: exploring technological change through period and birth cohort analysis.

Rachel L Knowles1, Catherine Bull, Christopher Wren, Carol Dezateux.   

Abstract

BACKGROUND: Technological advances in surgery, intensive care and medical support have led to substantial decrease in mortality for children with congenital heart defects (CHDs) over the last 50 years.
METHODS: Using routinely-collected mortality and population data for England and Wales from 1959 to 2009, the authors investigated age, period and birth cohort trends in child mortality attributable to CHDs.
RESULTS: The total number of deaths with CHDs at all ages between 1959 and 2009 was 61 903 (33 929 (55%) males). Absolute numbers of CHD-related deaths in children (under age 15 years) fell from 1460 in 1959 to 154 in 2009. Infants (aged under 1 year) comprised over 60% of all deaths due to CHD during the 5-year period 1959-1963, but this fell to 22% by 2004-2008. Age-standardised death rates have declined for both sexes but, despite narrowing sex differences, males continue to have higher death rates. Successive birth cohorts have experienced improved death rates in the first year of life; however, declining mortality across all age-groups has only been observed for birth cohorts originating after 1989. Poisson regression modelling predicts continuing generational decline in mortality.
CONCLUSIONS: Death rates attributable to CHDs have fallen dramatically with advances in paediatric cardiac surgery and intensive care, largely due to decreased mortality in infants aged under 1 year. Initially, mortality in later childhood rose as infant deaths fell, suggesting death was delayed beyond infancy. Children born within the last 20 years experienced lower mortality throughout childhood.

Entities:  

Mesh:

Year:  2012        PMID: 22753769     DOI: 10.1136/archdischild-2012-301662

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

Review 1.  MicroRNAs: pleiotropic players in congenital heart disease and regeneration.

Authors:  Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Total Energy Expenditure of Infants with Congenital Heart Disease Who Have Undergone Surgical Intervention.

Authors:  Jillian C Trabulsi; S Y Irving; M A Papas; C Hollowell; C Ravishankar; B S Marino; B Medoff-Cooper; J I Schall; V A Stallings
Journal:  Pediatr Cardiol       Date:  2015-06-21       Impact factor: 1.655

3.  Survival and Associated Risk Factors for Mortality Among Infants with Critical Congenital Heart Disease in a Developing Country.

Authors:  Mohd Nizam Mat Bah; Mohd Hanafi Sapian; Mohammad Tamim Jamil; Amelia Alias; Norazah Zahari
Journal:  Pediatr Cardiol       Date:  2018-05-14       Impact factor: 1.655

4.  Better health, less spending: Redesigning the transition from pediatric to adult healthcare for youth with chronic illness.

Authors:  Yana Vaks; Rachel Bensen; Dana Steidtmann; Thomas D Wang; Terry S Platchek; Donna M Zulman; Elizabeth Malcolm; Arnold Milstein
Journal:  Healthc (Amst)       Date:  2015-10-21

5.  Biomarkers improve prediction of 30-day unplanned readmission or mortality after paediatric congenital heart surgery.

Authors:  Jeremiah R Brown; Meagan E Stabler; Devin M Parker; Luca Vricella; Sara Pasquali; JoAnna K Leyenaar; Andrew R Bohm; Todd MacKenzie; Chirag Parikh; Marshall L Jacobs; Jeffrey P Jacobs; Allen D Everett
Journal:  Cardiol Young       Date:  2019-07-10       Impact factor: 1.093

Review 6.  Cellular and molecular basis of RV hypertrophy in congenital heart disease.

Authors:  D Iacobazzi; M-S Suleiman; M Ghorbel; S J George; M Caputo; R M Tulloh
Journal:  Heart       Date:  2015-10-29       Impact factor: 5.994

7.  Survival, by Birth Weight and Gestational Age, in Individuals With Congenital Heart Disease: A Population-Based Study.

Authors:  Kate E Best; Peter W G Tennant; Judith Rankin
Journal:  J Am Heart Assoc       Date:  2017-07-21       Impact factor: 5.501

8.  Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease.

Authors:  Andrew R Bond; Dominga Iacobazzi; Safa Abdul-Ghani; Mohammed Ghorbel; Kate Heesom; Mariangela Wilson; Christopher Gillett; Sarah J George; Massimo Caputo; Saadeh Suleiman; Robert M R Tulloh
Journal:  Open Heart       Date:  2018-01-03

9.  Mortality for Critical Congenital Heart Diseases and Associated Risk Factors in Newborns. A Cohort Study.

Authors:  Selma Alves Valente do Amaral Lopes; Isabel Cristina Britto Guimarães; Sofia Fontes de Oliva Costa; Angelina Xavier Acosta; Kyoko Abe Sandes; Carlos Maurício Cardeal Mendes
Journal:  Arq Bras Cardiol       Date:  2018-09-21       Impact factor: 2.000

10.  Mortality for Critical Congenital Heart Diseases and Associated Risk Factors in Newborns. A Cohort Study.

Authors:  Andressa Mussi Soares
Journal:  Arq Bras Cardiol       Date:  2018-11       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.